Octagon Capital Advisors LP - Significant Ownership

Signature - Title
Justin Hirsch - Chief Compliance Officer, Chief Financial Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Octagon Capital Advisors LP.

Significant Ownership of Octagon Capital Advisors LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GOSS Gossamer Bio, Inc. Common Stock, $0.0001 par value 8.6% $23.9M 19.6M Octagon Capital Advisors LP Dec 31, 2024
DNTH Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value 7.1% $44.9M 2.11M Octagon Capital Advisors LP Dec 31, 2024
TSHA Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value 5.1% $18M 10.5M Octagon Capital Advisors LP Dec 31, 2024

Schedules 13D/G Reported by Octagon Capital Advisors LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.